SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-129730
Filing Date
2022-04-29
Accepted
2022-04-29 06:08:01
Documents
3
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A d278983ddef14a.htm DEF 14A 344198
2 GRAPHIC g278983g001.jpg GRAPHIC 181513
3 GRAPHIC g278983g002.jpg GRAPHIC 91781
  Complete submission text file 0001193125-22-129730.txt   709920
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39617 | Film No.: 22869852
SIC: 2836 Biological Products, (No Diagnostic Substances)